Oral calcitriol and calcium: Efficient therapy for uremic hyperparathyroidism
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 34 (6) , 840-844
- https://doi.org/10.1038/ki.1988.258
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure.Journal of Clinical Investigation, 1986
- Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing DialysisNew England Journal of Medicine, 1986
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984
- A Microassay for 1,25-Dihydroxyvitamin D Not requiring High Performance Liquid Chromatography: Application to Clinical Studies*Journal of Clinical Endocrinology & Metabolism, 1984
- Abnormal Regulation of Parathyroid Hormone Release by Calcium in Secondary Hyperparathyroidism due to Chronic Renal Failure*Journal of Clinical Endocrinology & Metabolism, 1982
- Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis.BMJ, 1981
- Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophyKidney International, 1980
- 1,25 Dihydroxycholecalciferol Effects in Chronic DialysisAnnals of Internal Medicine, 1978
- Jejunal and ileal absorption in patients with chronic renal disease. Effect of 1alpha-hydroxycholecalciferol.Journal of Clinical Investigation, 1976
- Study of intestinal absorption of calcium in patients with renal failureKidney International, 1973